BioSpace News Archive

Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the second quarter 2019 on Tuesday, Aug. 6 at 9 a.m. ET.

Partnership will supply 14 essential medicines to US hospitals and patients

Crescendo Biologics Ltd announces that Takeda Pharmaceutical Company Limited, has exercised a second option under its existing, multi-target collaboration and license agreement.

Invitae Corporation, a leading medical genetics company, announced that it will report its second quarter 2019 financial results on Tuesday, August 6, 2019 and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.

PeriGen, the global leader in developing artificial intelligence systems for obstetrics, has partnered with specialist insurer Beazley to offer its safety-based obstetric program to Beazley’s healthcare clients in the United States.

DW Healthcare Partners, a private equity firm focused primarily on making control investments in North American middle market healthcare companies, announced the closing of its fifth fund.

evo® Cold Chain Management System and LifeGuard Same Day Service Reduce Risks for High-Value, Temperature-Sensitive Biologic Drugs

Law Firm Partners with IT Experts for Comprehensive Solutions

Patients with herniated discs in the Detroit area now have expanded options for spine surgery. Dr. Nilesh Patel now offers herniated disc repair utilizing the AnchorKnot® Tissue Approximation Kit.

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care products and services to office-based dental and medical practitioners, announced today that it will release its second quarter 2019 financial results before the stock market opens on Tuesday, August 6, 2019, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time